Bergman & Beving AB (publ) (BERG-B.ST) Stock Analysis
Bergman & Beving combines exceptional compounding quality and 50% gross margins with slow growth and substantial five-year multiple-compression risk.
Overview
Bergman & Beving is a Swedish industrial compounder founded in 1906 and widely regarded as the architect of the Scandinavian serial-acquisition model. Its approximately 40 autonomous business units operate in more than 25 countries, employ around 1,300 people, and generate roughly SEK 5 billion of annual sales. The portfolio is increasingly focused on proprietary, safety-critical technical products, which account for 82% of group sales and support approximately 50% gross margins. **The operating trajectory remains resilient:** Q1 FY2026/27 sales were MSEK 1,323, organic growth was 1%, adjusted EBITA rose 9% to MSEK 142, and the EBITA margin expanded to 10.7%, marking the 26th consecutive quarter of year-over-year profit growth. However, Machinery & Equipment suffered a sharp margin decline, while EPS of SEK 2.10 missed consensus. The shares trade at approximately 32.7x–33.27x P/E versus 19.4x for generic distributors. Catalysts include progress toward the 500/ten/45 target, UK acquisition integration, Machinery recovery, and macroeconomic improvement, but the five-year probability-weighted price of SEK 240.80 is below the SEK 287 reference price because multiple contraction dominates projected earnings growth.